Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity
European Journal of Nuclear Medicine and Molecular Imaging , Volume 32 - Issue 9 p. 1057- 1063
Purpose: This study assessed the incremental value of dobutamine stress 99mTc-tetrofosmin single-photon emission computed tomography (SPECT) for the prediction of cardiac events in diabetic patients with limited exercise capacity. Methods: The study population comprised 125 consecutive diabetic patients (mean age 61±9 years, 61% men) who were unable to perform an exercise test and underwent dobutamine 99mTc-tetrofosmin SPECT. Follow-up was successful in 124 (99%) patients. Three patients who underwent early revascularisation (within 60 days) were excluded. End-points during follow-up were cardiac death and non-fatal myocardial infarction. Results: An abnormal scan (with the presence of reversible or fixed perfusion defects) was observed in 76 (63%) patients. During the follow-up (3.4±1.5 years), 36 patients died (19 cardiac deaths) and four patients had non-fatal myocardial infarction. Cardiac death occurred in one of 49 (2%) patients with a normal myocardial perfusion study and in 18 of 75 (24%) patients with an abnormal study (p<0.001). Abnormal scan was incremental to the clinical parameters in predicting cardiac death (χ2=48 vs 39, p<0.05) and hard cardiac events (χ2=50 vs 43, p<0.05). Conclusion: Dobutamine stress 99mTc-tetrofosmin SPECT provides prognostic information additional to clinical data for the prediction of cardiac death and hard cardiac events in diabetic patients unable to perform an exercise test.
|99mTc-tetrofosmin, Diabetes mellitus, Prognosis, SPECT|
|European Journal of Nuclear Medicine and Molecular Imaging|
|Organisation||Department of Cardiology|
Pedone, C, Schinkel, A.F.L, Elhendy, A, van Domburg, R.T, Valkema, R, Biagini, E, … Poldermans, D. (2005). Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity. European Journal of Nuclear Medicine and Molecular Imaging, 32(9), 1057–1063. doi:10.1007/s00259-005-1815-y